Endotoxemia results in neutrophil localization within a number of microcirculatory beds, reflecting in part an adhesive interaction between neutrophils and the vascular endothelial cell. In previous studies, endotoxin or lipopolysaccharide (LPS) treatment of rabbits resulted in neutrophil sequestration at LPS concentrations well below those effective at increasing neutrophil adherence in vitro. We hypothesized that LPS-induced neutrophil adherence involved a plasma component. In the absence of plasma, high concentrations of LPS (10 micrograms/ml) were required to increase human neutrophil adherence to endothelial cells in vitro. With the inclusion of as little as 1% plasma or serum, however, the LPS doseresponse curve was markedly shifted, resulting in increments in adherence at 10 ng/ml, and the time course of enhanced adherence was accelerated. Pretreatment studies suggested that the effect of LPS was on the neutrophil rather than the endothelial cell. Immunoprecipitation of 0111:B4 LPS paralleled the loss of functional activity, suggesting that LPS was an integral part of the active complex, rather than altering a plasma component to make it active. The incubation of plasma with LPS decreased the apparent molecular mass of LPS from 500-1,000 kD to approximately 100 kD. The disaggregated 0111:B4 LPS eluted in the range of albumin and was able to increase adherence in the absence of additional plasma. 
required to increase human neutrophil adherence to endothelial cells in vitro. With the inclusion of as little as 1% plasma or serum, however, the LPS dose-response curve was markedly shifted, resulting in increments in adherence at 10 ng/ml, and the time course of enhanced adherence was accelerated. Pretreatment studies suggested that the effect of LPS was on the neutrophil rather than the endothelial cell. Immunoprecipitation of 0111:B4 LPS paralleled the loss of functional activity, suggesting that LPS was an integral part of the active complex, rather than altering a plasma component to make it active. The incubation of plasma with LPS decreased the apparent molecular mass of LPS from 500-1,000 kD to -100 kD. The disaggregated 0111:B4 LPS eluted in the range of albumin and was able to increase adherence in the absence of additional plasma. Plasma depleted of lipoproteins or heat treated retained activity, suggesting that the interaction of LPS with HDL or complement did not account for the observed findings. An LPSbinding protein isolated from rabbit serum enhanced the adherence-inducing effects of both 0111:B4 and Re595 LPS. Furthermore, the activity of rabbit serum was abolished after incubation with an antibody directed against this LPS-binding protein (LBP) . An antibody directed against CD14, the putative receptor of the LPS-LBP complex, prevented the adhesive response to LPS. These data suggest that LPS is disaggregated by an LBP in serum and plasma to form an active LPS-plasma component complex. This putative complex then interacts with CD14 on the neutrophil so as to induce an adhesive state. (J.
Introduction
Endotoxemia has been linked to a variety of catastrophic disorders, including acute lung injury ( 1, 2) , renal failure (3), disseminated intravascular coagulation (4) , and circulatory collapse (5) . Studies of the mechanisms by which bacterial endotoxins produce such severe reactions suggest that the biologically active lipopolysaccharide (LPS) portion ofendotoxin interacts with a variety of humoral and cellular mediators (6) . The neutrophil may play an important role in endotoxin-related syndromes (4, 5, 7) , but the mechanisms by which LPS enhances the injurious potential of neutrophils remains uncertain. The adherence ofneutrophils to vascular endothelium is a critical prelude to neutrophil-mediated injury (8) , and neutrophil sequestration in vascular beds in response to minute quantities of LPS has been recognized for decades (9) . Whether this effect represents a direct effect on the neutrophil (10) or the endothelial cell ( 11 ), or an indirect effect mediated through yet another mediator pathway ( 12) remains uncertain. Each has been proposed.
We demonstrated that ex vivo pretreatment of neutrophils with nanogram per milliliter concentrations of LPS in the presence of plasma enhanced neutrophil sequestration in the lung without requiring complement ( 13) . Dahinden et al. ( 10) similarly demonstrated the ability of low concentrations of LPS to induce human neutrophil adherence to plastic in the presence of plasma. These data contrast sharply with studies in which microgram per milliliter concentrations of LPS were required to exert effects in the absence of plasma ( 14) .
Accordingly, we sought to determine the effect of plasma and serum on LPS induction of neutrophil adhesion to endothelial cells. We hypothesized that the presence of plasma would facilitate LPS-induced neutrophil adhesiveness by complement-independent mechanisms. Our data suggest that LPSinduced neutrophil adhesion to endothelial cells is enhanced by plasma under circumstances in which LPS appears to be disaggregated. The were harvested by centrifugation at 12,000 g and washed thrice in sterile PBS. Radiolabeled LPS was extracted from the bacteria by the hot phenol-water procedure of Westphal and Jann ( 19) . Phenol-water extracted LPS was extensively dialyzed against distilled water, concentrated by ultrafiltration using a ym5 filter (Amicon, Beverly, MA) and diluted in sterile PBS. For other experiments, E. coli 0 11 :B4 LPS was radiolabeled with '25I using the benzimidate reaction (20). Both labeled LPS species were kind gifts from Dr. David Morrison.
Human and rabbit serum andplasma. Heterologous human serum was produced by clotting whole blood in LPS-free glass tubes. Serum was heat-treated at 56°C for 30 min and centrifuged at 500 gfor 10 min to remove any precipitate. Plasma was prepared from citrated whole blood centrifuged at 800 g for 20 min. The upper plasma layer was removed carefully, heat-inactivated, and centrifuged in a fashion similar to serum. Rabbit serum was obtained from normal animals and those undergoing an acute phase response as previously described ( 15) .
Cells. Human umbilical vein endothelial cells were harvested by collagenase digestion according to the method of Gimbrone et al. (21 ) and grown and characterized as previously described (22) . First passage cells were used after achieving confluence in microtiter wells.
Human blood neutrophils were prepared by a method which minimizes LPS exposure, using plasma-Percoll gradients as described by Haslett and co-workers (23) . After isolation, neutrophils were labeled with "'.In by first incubating 5 ,Ci "'.In (New England Nuclear, Boston, MA) with 100 Al of the chelating agent tropolone (4 X 10-3 M) (Fluka AG Buchs, FRG) for 5 min at 23°C, then adding the chelated "' In to 0.9 ml ofKRPD containing 3 X I07 neutrophils and incubating at 25°C for 5 min. The cells were then washed with 50 vol of KRPD and resuspended at a final concentration of 3 x 106/ml.
Neutrophil adherence assay. The adherence assay developed for these studies was a modification ofthe monolayer adhesion assay previously reported by Tonnesen and co-workers (22 (24) . Results are expressed as (a) the percentage of neutrophils which bound one or more beads and (b) the average number ofbeads adherent to those neutrophils that bound beads. Neutrophil superoxide production and priming by LPS was assayed as described by Guthrie and co-workers (25) .
Delipidation and delipoproteination of plasma. Fresh human serum from a pool of four donors was heat-inactivated and divided for extraction of lipid by two methods. Delipidation of the serum was achieved using the method of Cham and Knowles (26) . Serum (5 ml) containing 0.1 mg/ ml ethylene diamine tetraacetate (Sigma Chemical Co., St. Louis, MO) was added to 10 ml of 60% diisopropyl ether (DIPE) (Fisher Scientific Co., Fair Lawn, NJ), and 40% butanol in an LPS-free glass tube. The tube was rotated end over end for 30 min at room temperature, then centrifuged at 2,000 rpm for 2 min to clarify the layers. After transferring the organic layer to another tube the aqueous layer was extracted with an additional 5 ml ofDIPE for 10 min to remove traces of butanol. The organic material was dried under nitrogen and rehydrated in KRPD containing 4% human serum albumin. The aqueous phase was dialyzed in KRPD and the protein concentration was determined by the method of Lowry et al. (27) . It was tested in the adherence assay at a final protein concentration of 70 ,ug/ml along with the redissolved organic material, using a 1% solution of the original serum as a positive control. Density centrifugation was used to remove the lipoprotein from serum by a modification of the method of Esko and Matsuoka (28) . Briefly, an aliquot of serum was weighed and a saturated solution of NaBr (Fisher Scientific Co.) was slowly added until the density of the serum was increased to 1.21 g/ ml. The serum was then centrifuged in a model L5-50 ultracentrifuge (Beckman Instruments, Inc., Palo Alto, CA) with an SW 50.1 rotor at 40,000 g for 36 h. The lipoprotein layer was removed, the density was readjusted with the NaBr solution and the centrifugation was repeated. The delipoproteinated serum was dialyzed in KRPD, the protein concentration was determined and the serum was diluted and tested in the adherence assay at a final protein concentration of 70 g/ml.
Neutrophil pretreatment. Neutrophils were preincubated with LPS and serum and then assayed for adherence. In a 50-ml plastic centrifuge tube (Becton-Dickenson & Co., Oxnard, CA) a suspension of labeled neutrophils (20 x 106 in 0.5 ml) was mixed with 100 A1 serum and 100 ,l LPS (final concentration 10 ng/ml) and diluted to a final volume of 1 ml. Separate tubes containing neutrophils and buffer alone, LPS alone, or serum alone were prepared and all tubes were incubated for 10 min at 220C. 50 ml of saline was added to each tube and they were centrifuged 5 min at 800 rpm, then resuspended in KRPD at 3 x 106/ml. After this one high-volume wash, the pretreated cells were tested in the adherence assay, incubated with a buffer alone, LPS or serum alone, or the combination of LPS and serum.
Isolation and partial purification ofplasma components. Human serum was fractionated by DEAE sepharose (Pharmacia, Inc., Piscataway, NJ) chromatography to limit the amount of other protein for immunoprecipitation experiments. The DEAE column was equilibrated with 0.01 M PBS, pH 7.6, and the serum was dialyzed in the same buffer overnight. The precipitate that formed during dialysis was removed by centrifugation at 1,000 g for 15 min. Dialyzed serum (100 ml) was added to a 300-ml column and eluted with a sodium chloride gradient from 0.02 to 1 M NaCl in PBS. Fractions were collected, assayed for protein concentration, adjusted to a final concentration of 70 ,gg/ml, and tested for adherence-inducing activity. Active fractions were then reserved for immunoprecipitation studies. LBP was purified from rabbit serum as previously described ( 15) .
Preparation ofantisera to LBP. Polyclonal antisera to LBP were raised in goats as described ( 16), and IgG fractions prepared. Control antisera included nonimmune IgG, and antisera to rabbit IgG and fibronectin. Immunoprecipitation experiments using these sera were performed by incubating heparinized rabbit plasma with antisera ( 10 mg/ ml) to a final concentration of2 mg/ml, and incubated at 4VC for 18 h, then centrifuged at 14,000 g. Supernatants were collected and used to assay adherence.
LPS immunoprecipitation studies. Serum fractions from the DEAE column described previously that demonstrated the highest adherenceinducing activity were pooled and used for these experiments. A monoclonal antibody SB Mul ofserum and 250 ng of'25I-LPS (containing 2 X l05 cpm). After incubation, the sample was injected into an FPLCC system (Pharmacia Inc.) equipped with a Superose 12 column perfused at 1.0 ml/min with KRPD. Fractions ( 1.0 ml) were collected, protein measured by on-line analysis of the absorbance at 280 nm, and 1251 counts assessed by gamma well counting of fractions. Samples containing different molecular weight LPS were frozen immediately at -70°C and adherence activity studied by normalizing to equivalent numbers of 1251I counts.
The column was standardized using molecular weight markers (Sigma Chemical Co.). In other experiments 55 ng of LPS was incubated with 25 ng of '25I-LPS and 3.2 mg of human serum albumin in 200 Ml and treated similarly.
Statistics. Data were analyzed using a proprietary statistical package (Statistical Analysis System SAS, Cary, NC) operating on a VAX 11/750 computer and are reported as mean±SE. The data for time, concentration dependence, cation dependence and lipoprotein depletion experiments were analyzed using the SAS general linear models (GLM) procedure. For all of these analyses, a multiple comparison of the treatments was done using the Ryan-Einott-Gabriel-Welsh multiple-range test (29) and considered significant if P < 0.05.
Results
LPS-induced neutrophil adherence to endothelial cells: role of plasma. Absent plasma or serum, LPS concentrations of 1-1O ,ug/ml were required to enhance adherence of isolated human neutrophils to endothelial cells. The presence of 1% heat-inactivated plasma or serum shifted the concentration dependence of the neutrophil adherence response to LPS. Fig. 1 demonstrates the concentration dependence of. LPS from smooth strain E. coli 01 1 l:B4 for stimulation of neutrophil adherence to both human umbilical vein endothelial cells (Fig. 1 A) , and serum-coated plastic (Fig. 1 B) . In the presence of plasma the response is 2-3 logs more sensitive than when LPS is incubated with neutrophils in the presence of buffer alone. Experiments Endothelial Cells In the absence of plasma, LPS-induced increases in neutrophil adherence to either serum-coated plastic or endothelial cells required at least 60 min for the full expression of adherence (Fig. 2) . However, in the presence of 10% plasma, 1 ,ug/ ml LPS produced a detectable increase in adherence as early as 15 min after exposure (Fig. 2 B) , whereas 10 ng/ml LPS induced adherence at 30 min (Fig. 2 A) . The differences between buffer and plasma-treated cells are even more apparent at low concentrations of LPS (10 ng/ml, Fig. 2 A) . The relative slowness of development of LPS-induced adherence contrasts with FMLP-induced adherence where adherence is detectable within seconds (22) .
To compare the adherence induced by LPS and a more traditional stimulus, the cation requirements for binding were determined in the presence of serum. As shown in Table I , in the absence of Ca++ and Mg++ (in the presence of the chelator EDTA) the baseline adherence was lowered, but LPS was still able to increase adherence twofold (P < 0.01 ). The addition of Mg+ ( 1 mM) was accompanied by an increase in the baseline adhesion, and a similar twofold increase in adherence with LPS. In the presence of Mg", addition of Ca++ had an added -effect to increase LPS-induced adherence, comparable in magnitude to that observed with unchelated serum in Fig. 1 B. Pretreatment studies. We carried out pretreatment studies to determine whether the effect of serum and LPS was concerted or sequential, and whether the combination acted on the against that LPS were designed to determine if LPS was an integral part ofthe adherence-inducing activity, or merely modified a plasma component to make it active. After incubating radiolabeled [3H ] LPS with partially purified serum, LPS was precipitated from the mixture by varying amounts ofmonoclonal antibody, and the supernatant tested for both adherence-inducing activity and the amount of [3H ] LPS remaining. Fig. 3 demonstrates that as LPS is bound and precipitated from the mixture, the adherence-inducing activity decreases, and there is a correlation between the amount of LPS removed and the inhibition of adherence. The addition of protein A sepharose beads alone had no effect on the apparent activity of the LPSplasma incubation in the absence of 5B10 antibody (data not shown).
Adhesion ofbeads to the neutrophil surface. Effect ofplasma on the physicochemical properties ofLPS: relationship to activity. In light of the pioneering studies of Rudbach and co-workers (31 ) suggesting that plasma disaggregated LPS, we questioned whether the apparent molecular mass ofLPS would be affected by this interaction. The fractionation of LPS on gel filtration FPLC is shown in Fig. 5 . Fig. 5 We also measured the adherence-increasing activities ofthe high and low molecular mass fractions. As shown in Fig. 6 , 0111:B4 LPS at 100 ng/ml was able to increase adherence of neutrophils for beads only in the presence of 1% serum. Similarly, 100 ng/ml LPS from the high molecular fractions (fraction 9 in Fig. 5 B) was only effective at increasing adherence in the presence of 1% serum. In contrast, the low molecular weight fractions (fraction 13 in Fig. 5 B) increased adherence in the absence of any added serum. Thus, LPS incubated with serum is shifted to lower molecular mass components that appear to increase adherence.
Characterization of the plasma activity. The best-studied interaction between LPS and plasma has been that between LPS and HDL (32, 33) . To determine whether formation of a complex between LPS and HDL could account for the enhancement provided by plasma, we depleted plasma of lipoproteins. As shown in Table II , plasma depleted of lipoproteins retained the ability to enhance the action of LPS on neutrophil adherence, suggesting that interaction of LPS with HDL did not account for the observed activity.
Recently, one LBP has been purified from rabbit serum ( 15) and cloned ( 16) . We measured the ability of purified rabbit LBP to replace the effect of serum in studies ofLPS-induced neutrophil adherence (in this case to serum-coated plastic). As shown in Fig. 7 , LBP ( 10-2,000 ng/ml) induced a concentration-dependent enhancement of the responses to both 0 1 1 :B4 and Re595 LPS. These data suggested that LBP might be an important component of the plasma processing of both Re595 and 01 1 1:B4 LPS. To further address this latter question, rabbit serum was depleted offunctional LPB. Depletion ofLBP by complexing with goat anti-rabbit LBP (GAR-LBP) abolished the ability of normal rabbit serum to enhance the effect of 011 1 :B4 LPS (Fig. 8) Figure 5 . Activity of column buffer with addition of 100 ng/ml 011 1:B4 LPS in the presence or absence of 1% serum is compared with activity of high molecular weight LPS (fraction 9) or low molecular weight LPS (fraction 13) as in Figure 5 . Only the low molecular weight LPS is active absent added serum. *P < 0.05 when compared to buffer-containing wells. **No difference between plasma and buffer-containing conditions. sary for rabbit serum enhancement of LPS-induced neutrophil adherence.
Targets ofLPS in the context ofLBP. Since neutrophil preparations may contain as much as 0.5-1% monocytes, we considered the possibility that tumor necrosis factor (TNF), released from LPS-exposed monocytes, might stimulate neutrophil adherence (34) . Using the bead adhesion system, we first determined that a monoclonal anti-TNF antibody, supplied courtesy of Richard Ulevitch (Scripps Institute, La Jolla, CA), and a kind gift of Peter M. Henson (National Jewish Center, Denver, CO), was able to prevent TNF-induced neutrophil adherence (data not shown). Used in the same concentration, however, this antibody had no effect on the number of beads bound to the neutrophil surface in response to LPS in 10% serum, nor did it inhibit priming of neutrophils for enhanced superoxide secretion (another function enhanced by plasma [35] perhaps secondary to LBP [36] ) (data not shown).
The cellular target for complexes of LPS and LBP has recently been suggested to be CD 14 See Methods for extraction procedures. The adherence of neutrophils to serum-coated plastic wells was studied after 40 min at 370C±LPS at 100 ng/ml. The protein concentrations of all serum samples were adjusted to 70 ,g/ml. * Different from buffer (P < 0.05).
lated on neutrophils by a variety of stimuli (38) . In order to determine whether LPS stimulation of adherence required interaction with CD 14, we incubated neutrophils with two antibodies directed against different epitopes ofthis surface component. The antibody Mo2, which labels neutrophils poorly, had no effect on neutrophil adherence induced by LPS. In contrast, MY4, which binds to neutrophils (data not shown) and labels a single 52-kD band from neutrophil membranes (Fig. 9 , inset) completely inhibited LPS-induced neutrophil adherence (Fig.  9) . Furthermore, in data not shown, staining of neutrophils by MY4 was abrogated by prior incubation of the cells with a phosphotidylinositol-specific phospholipase C but not by a phosphotidylcholine-specific phospholipase C, consistent with data from other cells that CD 14 is attached by a phosphotidylinositol linkage. Pretreatment with the phosphatidylinositolspecific, but not the phosphatidylcholine-specific phospholipase C abrogated the adhesive response to LPS, but had no effect on the adhesive response to FMLP (data not shown).
by which LPS increases neutrophil adherence focused on the ability ofLPS to activate complement and generate potent neutrophil chemotaxins ( 12) . However, Dahinden and colleagues (10) demonstrated that LPS could increase adherence in the presence of heat-inactivated plasma wherein complement activation was prevented. Haslett et al. ( 13) extended the studies of Dahinden et al. (10) by incubating isolated rabbit neutrophils with LPS in the presence ofheat-treated plasma, and then after washing, reinfusing them into recipient rabbits. In contrast to control neutrophils incubated ex vivo, the LPS-treated cells were retained for long periods of time within the lung vasculature, and there was no evidence of complement activation on the surface of neutrophils. These two studies present persuasive evidence that LPS-induced neutrophil adherence, and sequestration of neutrophils in vascular beds, proceeds by a complement-independent effect. In this study, we investigated the role of plasma or serum components in the modulation of LPS-induced neutrophil adherence. We found that although LPS inDiscussion LPS has been shown to interact with a number of plasma components, including complement proteins (12) , lipoproteins (32) , albumin (39) , native anti-LPS antibodies (40) , and recently described LBPs ( 15 ) . Early studies of the mechanisms (32) .
Here we have presented evidence confirming that smooth LPS was converted from high molecular mass aggregates to lower molecular mass aggregates (100 kD) when incubated with serum. Furthermore, the LPS so converted appeared to be more active than native LPS in the absence of added serum. While this might reflect a greater number of molecules available for binding, it cannot entirely account for the shift in dose-response characteristics. Accordingly, it seems apparent that both the aggregation state and the nature of the complex formed between LPS and those plasma constituents with which it interacts are crucial determinants of the functional activity that results (see also reference 41 ).
The serum components responsible for these alterations are beginning to be characterized, and are the subject of current study. The LBP identified in acute phase rabbit serum is an attractive candidate ( 15 ) , as it is the only protein so far shown to bind to LPS at physiological concentrations. It has been shown to bind avidly to Re595 LPS, and has recently been shown to enhance the effects ofboth 011 :B4 and Re595 LPS on monocytes ( 16) . Here we have demonstrated the ability of this protein to enhance LPS-induced neutrophil adherence. Furthermore, the ability of rabbit serum to enhance LPS-induced adherence of neutrophils is abolished by antibodies against this protein. These data suggest that LBP may be necessary for serum enhancement of LPS activity. Whether it is the only such molecule in rabbit serum is unclear, and its precise role in human serum remains uncertain. Definitive elucidation of these complex events in the human requires purification of human LBP, and separation of all relevant activities. It is of interest that purified LBP, even in high concentrations, does not increase the activity ofLPS as much as does serum containing lower concentrations of LBP. These observations raise the possibility that other serum components, such as albumin (42, 43) may also contribute to the response of neutrophil populations.
Recent work suggests that the complex of LPS with LBP binds to CD14 on the surface of the monocyte (37) and the neutrophil (38) , supporting the notion that it is not merely the smaller size but different presentation that enhances activity. A recent study by Wright and Ramos (38) indicates that the complex of LPS and LBP binds to CD14 on the neutrophil surface and induces adherence through upregulation of CR3. Here we have demonstrated that antibodies directed against one epitope ofCD 14 block the response to serum-enhanced neutrophil ad-hesive response to LPS. Furthermore, treatment ofthe neutrophil with phosphatidylinositol-specific phospholipase C that decreases staining by anti-CD 14 antibodies also prevented the neutrophil response to serum.
Many adhesive responses demonstrated for neutrophils exposed to more traditional neutrophil stimuli appear to require the involvement of the CDl 1 /CD1 8 complex of adhesive glycoproteins (44) . Although not addressed in this study, the mechanism by which LPS increased adherence has been shown by us to also involve this complex.2 Furthermore, surface expression of CD 18 was enhanced by serum in a fashion parallel to the increase in adhesion shown here.2 These data suggest an important role for the CDl 1 /CD1 8 complex in mediating neutrophil adherence induced by LPS in serum. A role for LPS and LBP in the activation of CDl 1 /CD1 8 was suggested recently by Wright and colleagues (38) .
New information from several studies now permits a more detailed appreciation of the response of the organism to LPS. LBP appears essential for the serum enhancement of LPS induction of adherence (this work) or priming (36) in neutrophils, or of TNF synthesis by monocytes (37) . The formation of an LPS-LBP complex (16) then allows interaction with CD 14 on both the surface of the neutrophil (this work and see also reference 38) and monocyte (37) . Finally, this interaction leads to increased adhesiveness by the neutrophil, due in part to up-regulation of CDl 1/18 (38).2 Our study suggests that LBP in serum is not only capable ofenhancing LPS-mediated adherence, but functions as a critical part of the serum response to LPS, and that LPS modified by serum or plasma requires interaction with CD14 on the surface of leukocytes. Accordingly, studies ofthe interaction between LPS and serum components may yield clues to the pathogenesis of a variety of infectious and inflammatory disorders.
